Caffeine and Cocaine

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Cocaine Dependence

In brief

This study is being done to find out if medicines that affect a neurotransmitter (chemical messenger) in the brain called adenosine improve behavioral problems that are related to drug abuse. Another purpose of the study is to find out how genes related to adenosine change how people respond to these medicines. More information about how these medicines change behaviors may be helpful to come up with new treatments for drug abuse.

Key facts

Study ID
NCT00733993
Run by
Virginia Commonwealth University
People needed
23
Starts
2008-04-01
Expected to finish
2011-10-01
Last updated by the study team
2017-03-22

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.